Delivery Order SPE2DB20D3111-SPE2DB25FA9AT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, valued at $3,574.80 with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,362.20 on September 4, 2025, for the supply of BOTOX Cosmetic 100-unit vials, with an ultimate completion date of September 25, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of BOTOX Cosmetic 100-unit vials with a ceiling value of $1,787.40. This firm fixed-price delivery order, which is expected to be completed by October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract was competitively awarded without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,574.80 on September 15, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with a ceiling value of $4,021.65 and an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $6,702.75 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for Botox Cosmetic 100 Unit Vials with an ultimate completion date of September 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed-price contract valued at $5,168.16. The award was made on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9ATDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX Cosmetic under a firm fixed-price contract valued at $1,787.40. The award, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor contract (SPE2DX) valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military and federal healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor, fulfills critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through this expansive contract framework, demonstrating its established capability to meet specialized federal medical supply requirements on an expedited basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/21/25 |